Skip to content

Conjunctival flap surgery as a treatment for chronic and therapy-resistant ocular surface disorders

Conjunctival flap surgery as a treatment for chronic and therapy-resistant ocular surface disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039689
Enrollment
95
Registered
2026-04-20
Start date
2026-03-27
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H16.0 H16.8 H16.9

Interventions

Group 1: The present study is designed as a retrospective observational study. No study-related intervention is performed. Clinical routine data of patients who underwent partial or complete conjunct

Sponsors

St. Johannes Hospital Dortmund, Klinik für Augenheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent partial or complete conjunctival flap surgery between 2013 and 2023 at the Department of Ophthalmology, St. Johannes Hospital Dortmund.

Exclusion criteria

Exclusion criteria: No specific exclusion criteria are defined, as all patients who underwent conjunctival flap surgery within the defined study period are included, provided sufficient clinical documentation is available.

Design outcomes

Primary

MeasureTime frame
Primary outcome is the treatment success defined as the absence of severe postoperative surgical interventions (e.g., keratoplasty or enucleation) following conjunctival flap surgery. This parameter is assessed during the entire follow-up period. Data are collected retrospectively from clinical routine documentation (medical records and surgical reports).

Secondary

MeasureTime frame
Secondary outcomes include postoperative complications (e.g., conjunctival flap retraction), the need for additional surgical interventions, and functional outcomes (e.g., visual acuity and intraocular pressure). In addition, preoperative risk factors, comorbidities, and previous surgeries, as well as their potential impact on treatment success, are analyzed. Data are collected retrospectively from clinical routine documentation.

Countries

Germany

Contacts

Public ContactHarald Schilling

Klinik für Augenheilkunde, St. Johannes-Hospital Dortmund

harald.schilling@joho-dortmund.de(0231) 18 43 - 35 460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026